Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy
This study has been completed.
The Miriam Hospital
Tufts Medical Center
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Aadia Rana, The Miriam Hospital
First received: April 23, 2009
Last updated: April 16, 2014
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||April 2014|
|Primary Completion Date:||June 2012 (Final data collection date for primary outcome measure)|